Physician profile
Gaston Dana
NPI 1225130610
$13,258.45
in general payments reported to CMS, 2019-2025
80 companies · $2,845 in 2025
The $2,845 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,018 · 2020: $1,596 · 2021: $101 · 2022: $875 · 2023: $2,117 · 2024: $2,706 · 2025: $2,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,657 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,657.01 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,847.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,165.34 | 2019-2025 | Evenity, Repatha, Otezla |
| Medtronic Vascular, INC. | $1,134.87 | 2019 | |
| Abbvie INC. | $1,005.10 | 2019-2025 | Linzess, Vraylar, Viberzi |
| Lilly USA, LLC | $664.59 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $513.97 | 2019-2025 | Farxiga, Bevespi Aerosphere |
| Glaxosmithkline, LLC. | $507.79 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Smith+Nephew, INC. | $499.31 | 2020-2025 | Grafix Pl, Stravix, Oasis |
| Pfizer INC. | $487.64 | 2019-2025 | |
| Corcept Therapeutics | $397.99 | 2020-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.56 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $317.88 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $263.18 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Astellas Pharma US INC | $235.78 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $214.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $212.27 | 2019-2024 | |
| Tandem Diabetes Care, INC. | $209.67 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $205.46 | 2022-2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $199.28 | 2022-2024 | Minimed 780g, Venaseal, Closurefast |
| Abbott Laboratories | $168.09 | 2019-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $165.17 | 2019-2025 | Glassia, Trintellix |
| Axsome Therapeutics, INC. | $117.96 | 2024-2025 | Auvelity |
| Bard Peripheral Vascular, INC. | $105.75 | 2022-2025 | Venclose Maven Catheter |
| Sanofi-Aventis U.S. LLC | $105.61 | 2019-2023 | |
| Mylan Specialty L.P. | $104.87 | 2019-2020 | |
| Tactile Systems Technology INC | $103.19 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Bayer Healthcare Pharmaceuticals INC. | $99.56 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $95.81 | 2019-2023 | Eliquis |
| Paratek Pharmaceuticals, INC. | $94.45 | 2019-2024 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $88.87 | 2024-2025 | Voquezna |
| Urgo Medical North America, LLC | $85.69 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Merck Sharp & Dohme LLC | $79.04 | 2019-2023 | Belsomra |
| Averitas Pharma INC. | $77.32 | 2023-2025 | Qutenza |
| Kerecis Limited | $68.88 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Otsuka America Pharmaceutical, INC. | $67.03 | 2024-2025 | Rexulti |
| Medtronic Minimed, INC. | $61.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.16 | 2019-2023 | Xifaxan |
| Ani Pharmaceuticals, INC. | $57.42 | 2025 | Purified Cortrophin Gel |
| Sanofi Pasteur INC. | $50.23 | 2019-2023 | |
| Almatica Pharma LLC | $49.89 | 2023-2025 | Loreev Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $47.08 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.36 | 2025 | Caplyta |
| Philips North America LLC | $45.63 | 2019 | |
| Misonix INC | $44.04 | 2020 | |
| Neurocrine Biosciences, INC. | $40.54 | 2025 | |
| Insulet Corporation | $37.90 | 2023-2025 | Omnipod |
| Ibsa Pharma INC. | $35.94 | 2023-2025 | Tirosint, Tirosint, Licart |
| Reapplix INC. | $34.93 | 2024 | 3c Patch Kit - Box |
| Idorsia Pharmaceuticals US INC | $30.43 | 2023-2024 | Quviviq |
| Convatec INC. | $29.44 | 2022-2024 | |
| Kyowa Kirin, INC. | $28.54 | 2025 | |
| Sumitomo Pharma America, INC. | $27.95 | 2024 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $27.91 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $26.80 | 2023 | |
| Antares Pharma, INC. | $26.51 | 2024 | Xyosted |
| Sunovion Pharmaceuticals INC. | $23.76 | 2019 | |
| Integra Lifesciences Corporation | $23.19 | 2019 | |
| Welch Allyn | $22.94 | 2020 | |
| Kci USA, INC. | $22.69 | 2020 | |
| Acera Surgical, INC. | $21.10 | 2022 | |
| Bsn Medical INC | $20.79 | 2024 | |
| Allergan, INC. | $20.17 | 2019 | |
| Molnlycke Health Care US, LLC | $19.83 | 2024 | Exufiber Ag+, Mepitel Ag |
| Grifols USA, LLC | $18.69 | 2019 | |
| Triad Life Sciences INC. | $18.32 | 2022 | |
| Eisai INC. | $18.10 | 2020 | |
| Shire North American Group INC | $16.57 | 2019 | |
| Esperion Therapeutics, INC. | $15.66 | 2025 | Nexletol |
| Amarin Pharma, INC. | $15.45 | 2020 | |
| Boston Scientific Corporation | $15.32 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.19 | 2019 | |
| Halozyme INC | $14.12 | 2023 | |
| Coloplast Corp | $13.69 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2025 | Zoryve |
| Daiichi Sankyo INC. | $12.74 | 2019 | |
| Lifescan, INC. | $12.70 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.75 | 2021 | |
| Pulmonx Corporation | $10.89 | 2019 | |
| Medela LLC | $10.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaston Dana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.